158 related articles for article (PubMed ID: 34960901)
1. Utilization of Gelling Polymer to Formulate Nanoparticles Loaded with Epalrestat-Cyclodextrin Inclusion Complex: Formulation, Characterization, In-Silico Modelling and In-Vivo Toxicity Evaluation.
Alvi Z; Akhtar M; Rahman NU; Hosny KM; Sindi AM; Khan BA; Nazir I; Sadaquat H
Polymers (Basel); 2021 Dec; 13(24):. PubMed ID: 34960901
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Oral Bioavailability of Epalrestat SBE
Alvi Z; Akhtar M; Mahmood A; Ur-Rahman N; Nazir I; Sadaquat H; Ijaz M; Syed SK; Waqas MK; Wang Y
Int J Nanomedicine; 2021; 16():8353-8373. PubMed ID: 35002232
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: In vivo toxicity evaluation.
Sadaquat H; Akhtar M; Nazir M; Ahmad R; Alvi Z; Akhtar N
Int J Pharm; 2021 Apr; 598():120363. PubMed ID: 33556487
[TBL] [Abstract][Full Text] [Related]
4. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dissolution and skin permeation profiles of epalrestat with β-cyclodextrin derivatives using a cogrinding method.
Furuishi T; Takahashi S; Ogawa N; Gunji M; Nagase H; Suzuki T; Endo T; Ueda H; Yonemochi E; Tomono K
Eur J Pharm Sci; 2017 Aug; 106():79-86. PubMed ID: 28546106
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
[TBL] [Abstract][Full Text] [Related]
7. Polymer-free electrospun nanofibers from sulfobutyl ether
Yildiz ZI; Celebioglu A; Uyar T
Int J Pharm; 2017 Oct; 531(2):550-558. PubMed ID: 28445768
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization, and
Zhang Z; Chen J; Zou L; Tang J; Zheng J; Luo M; Wang G; Liang D; Li Y; Chen B; Yan H; Ding W
Int J Nanomedicine; 2022; 17():5287-5302. PubMed ID: 36411767
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.
Elmoghayer ME; Saleh NM; Abu Hashim II
Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
[TBL] [Abstract][Full Text] [Related]
12. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
[TBL] [Abstract][Full Text] [Related]
13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: Preparation, characterization and intestinal mucosal immunity in mice.
He M; Zhong C; Hu H; Jin Y; Chen Y; Lou K; Gao F
Asian J Pharm Sci; 2019 Mar; 14(2):193-203. PubMed ID: 32104451
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
[TBL] [Abstract][Full Text] [Related]
17. In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia.
Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; Kaya Z; Ozel AE; Akyuz S
Curr Comput Aided Drug Des; 2020; 16(2):104-121. PubMed ID: 31244443
[TBL] [Abstract][Full Text] [Related]
18.
Zhang L; Yang S; Wong LR; Xie H; Ho PC
Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
[TBL] [Abstract][Full Text] [Related]
19. Morin-VitaminE-β-CyclodextrinInclusionComplexLoadedChitosanNanoparticles (M-Vit.E-CD-CSNPs) Ameliorate Arsenic-Induced Hepatotoxicityina Murine Model.
Mondal S; Das S; Mahapatra PK; Saha KD
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144555
[TBL] [Abstract][Full Text] [Related]
20. Development and physicochemical characterization of chitosan hydrochloride/sulfobutyl ether-β-cyclodextrin nanoparticles for cinnamaldehyde entrapment.
Zhu W; Wu J; Guo X; Sun X; Li Q; Wang J; Chen L
J Food Biochem; 2020 Jun; 44(6):e13197. PubMed ID: 32189350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
